Diabetes

Scientists have developed smart insoles that accurately measure the forces created when a foot hits the ground in the real world. The tech has a range of applications, from assisting in rehabilitating patients to helping athletes prevent injuries.

Researchers at the National University of Singapore have hit upon new technologies to deliver a double whammy to chronic wounds in diabetics, using tiny needles barely visible to the human eye.

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year.

Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to protect against obesity in mice on a high-fat diet, specifically by suppressing the formation of white fat cells.

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of people who were diabetic before the surgery, meant that they didn’t require diabetes medication five years after.

Scientists remain puzzled as to why some people taking popular weight loss and diabetes medications like Ozempic and Wegovy are losing their vision suddenly, highlighting that there's still so much we don't know about this life-changing class of drugs.

Researchers have created a way to guide and control the development of stem cells into specific tissues and organs, opening the door to developing a means of one day tackling complex diseases like diabetes and Parkinson’s disease.

An innovative mix of readily available natural products shapes up as a long-term alternative to the likes of Ozempic for managing obesity, diabetes, liver health and inflammation – without the injections, cost or side effects associated with GLP-1 drugs.

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac function, according to new research. The findings open the door to developing a new treatment for diabetes-induced heart disease.

If you've never heard of fox nuts, you'd be forgiven for assuming that they don't seem particularly palatable. But they're actually starchy seeds harvested from an aquatic lily that boast vast health benefits. And no foxes are harmed in the process.

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. It could be an effective alternative to regular injections of medication directly into the eye.